Science
Scientific rigor as foundation.
Origin
Quanttrace is a spin-off from the Laboratory of Neuroengineering (ITECA - UNSAM), an interdisciplinary neurotechnology lab with over 20 researchers across biomedical engineering, medicine, data science, and social sciences.
Laboratory of Neuroengineering — UNSAM
Led by Dr. Daniela Andres, LabNIng applies engineering, mathematical, and anthropological approaches to understand neural systems and develop assistive technologies. Research lines span Parkinson's disease, ataxia, neural signal processing, AI in cardiology, and neuro-glial system simulation.
labning.com.arMilestones
BIO Boston 2025
Selected for the Argentine delegation at the world's largest biotech conference (AAICI/Chancellery)
Patent Pending — USPTO
International protection for Lumitrace technology — App. #63/824,295
Clinical Validation
Cardiotrace clinical validation protocol in preparation. Awaiting formal protocol initiation.
U$150,000 Investment
Private round closed in 2025.
Collaborations
UNSAM
University of origin. Laboratory of Neuroengineering, Biomedical Engineering faculty.
FLENI Institute
Research collaboration in movement disorders and neurophysiology.
Circular Cowork
Accelerator and investor. Mentorship, infrastructure, fabrication lab.
Technology Readiness (TRL)
Cardiotrace
Validated in clinical environment — clinical protocol pending funding
Lumitrace
Validated in laboratory — ongoing mouse trials with positive results
Our development follows a rigorous progressive validation process: from laboratory proof of concept, through preclinical trials, to validation in a relevant clinical environment. Each product advances through Technology Readiness Levels (TRL) with the generation of publishable scientific evidence.